Formulation and Evaluation of Effervescent Floating Tablet of Amlodipine besylate

Size: px
Start display at page:

Download "Formulation and Evaluation of Effervescent Floating Tablet of Amlodipine besylate"

Transcription

1 Research J. Pharm. and Tech. 1(4): Oct.-Dec. 28, ISSN RESEARCH ARTICLE Formulation and Evaluation of Effervescent Floating Tablet of Amlodipine besylate Pare A, Yadav SK and Patil UK* V N S Institute of Pharmacy, V N S Campus, Vidya Vihar, Barkheda Nathu, Neelbud, Bhopal (M P) * Corresponding Author umeshpatil29@yahoo.com ABSTRACT Amlodipine besylate effervescent floating tablets were developed in ten different formulations (F1 to F1) by employing different grades of polymers and effervescent agents such as sodium bicarbonate and citric acid. The formulations were evaluated for various physical parameters, buoyancy studies, dissolution parameters and drug released mechanisms. F1 formulation showed maximum floating time of 24 hours and gave slow and maximum drug release of Amlodipine besylate spread over 24 hours and whereas Amlodipine besylate released from marketed tablet was rapid and maximum within 12 hours. KEY WORDS Amlodipine besylate, Effervescent floating tablet. INTRODUCTION: Effervescent floating drug delivery systems generate gas (CO 2 ), thus reduce the density of the system and remain buoyant in the stomach for a prolonged period of time and released the drug slowly at a desired rate. 1,2,3 Amlodipine is long acting calcium channel blocker and used in the treatment of hypertension, and chronic stable angina. In hypertension or angina, initially 5 mg. one daily and adjusted to maximum dose 1 mg one daily dose of Amlodipine is given orally. 4 Amlodipine has maximum solubility in acidic ph. Amlodipine has some adverse effect such as nausea, abdominal pain. Effervescent floating tablet of Amlodipine besylate retain in stomach improves solubility, bioavailability, reduces drug waste and decrease side effect such as gastric irritation and nausea. 5, 6 In present work, effervescent floating tablets of different formulation were developed with an objective of achieving 24 hrs floating and drug release time and the effervescent floating tablet was compared with marketed formulation of Amlodipine besylate for drug released time. Received on Modified on Accepted on RJPT All right reserved Research J. Pharm. and Tech. 1(4): Oct.-Dec. 28;Page EXPERIMENTAL Materials Amlodipine besylate was procured from Signa Pharma Pvt. Ltd. Kanpur. HPMC K1 M, HPMC K15 M, Carbapol 934 p, Sodium biacarbonate, Citric acid, poly vinyl pyrrolidine and Talc were obtained from Colorcon Asia Pvt. Ltd and Loba chemicals. Amlosafe 1 (marketed brand of Amlodipine besylate) tablets were purchased from local market. Methods Effervescent Floating tablets containing Amlodipine besylate were prepared by direct compression technique using varying concentrations of different grades of polymers with Sodium bicarbonate and citric acid. All the ingredients were accurately weighed and passed through different mesh sieves accordingly. Then, except Magnesium stearate all other ingredients were blended uniformly in glass mortar After sufficient mixing of drug as well as other components, Magnesium stearate was added, as post lubricant, and further mixed for additional 2-3 minutes. The tablets were compressed using rotary tablet machine. The weights of the tablets were kept constant for all formulation. Evaluation of effervescent floating tablet formulations Hardness of the tablets was tested using a Monosanto hardness tester. Friability of tablets was determined in Roche friabilator. Ten tablets were selected randomly from each batch and weighed individually to check for weight variation. The results are given in table no

2 Research J. Pharm. and Tech. 1(4): Oct.-Dec. 28, Invitro Dissolution Release Time(hrs) Figure 1: In-vitro dissolution profile of formulations F 1 to F 9 Invitro Dissolution Data 12 F1 F2 F3 F4 F5 F6 F7 F8 F9 Log Cumulative % Drug Retained First Order Release Kinetics y = -.729x R 2 = Log Cum % Drug Retained Time (hrs) Linear (Log Cum % Drug Retained) Figure 4: Plot of log cumulative percentage drug retained vs. time of optimized formulation (F1) [First order] Higuchi Release Mechanism Time (Hrs) Figure 2: In-vitro dissolution profile of optimized formulation (F 1) Zero Order Relaese Kinetics F y = x R 2 = cumulative % drug release Root Of Time Linear Cumulative % drug release Figure 5: Plot of cumulative percentage drug released vs. root time of optimized Formulation (F1) [Higuchi Matrix] y = x R 2 = Cum % Release Linear (Cum % Release) Time (hrs.) Log Cumulative % Drug Released Korsmeyer & Peppas Release Mechanism y =.691x R 2 = Log Time Figure 3: Plot of cumulative percentage drug released vs. time of optimized formulation (F1) [Zero Order] The buoyancy lag time (BLT) and total floating time (TFT) 7 On immersion of tablets of different formulations in.1n HCl solution at 37±5 C, the tablets floated, and remained buoyant without disintegration, the results of the buoyancy lag time (BLT) and total floating time (TFT) were shown in Table 3. Estimation of Amlodipine besylate 8 Amlodipine besylate content in the tablets was estimated by using UV spectrophotometric method based on the measurement of absorbance at λ max 239 Log Cum % Drug Release Linear (Log Cum % Drug Release) Figure 6: Plot of log cumulative percentage drug released vs. log time of optimized formulation (F1) [Korsmeyer and Peppas Model] nm in phosphate buffer 7.4. Amlodipine besylate content of the tablets are given in Table 4. Drug release study In vitro release studies of F1 to F1 formulations and one brand of Amlodipine besylate were carried out in the dissolution test apparatus (USP Type II). The tests were carried out in 9 ml of dissolution media 7.4 ph buffers for 24 hrs at 5 rpm at 37±.5 C 1 ml of the aliquot were withdrawn at different predetermined time intervals (.5, 1, 527

3 Research J. Pharm. and Tech. 1(4): Oct.-Dec. 28, Table 1: Composition of all the Formulations (F1 F1) Ingredient F1 F2 F3 F4 F5 F6 F7 F8 F9 F1 Amlodipine HPMC K1M HPMC K15M Carbopol 934P MCC Sodium Bicarbonate Citric Acid Poly vinyl Pyrrolidine K Magnesium Stearate Talc Aerosil Total weight *All the quantities are in mg Table 2: Hardness, Friability, Weight variation of tablets of different formulation F1 to F1 Formulation Hardness (Kg/cm 2 ) Friabilit y (%) Weight Variation (mg) F1 4.5 ± ±5% F2 4.4 ± ±5% F3 4.4 ± ±5% F4 4.3 ± ±5% F5 4.5 ± ±5% F6 4.5 ± ±5% F7 4.5 ± ±5% F8 4.3 ± ±5% F9 4.4 ± ±5% F1 4.4 ± ±5% *Values are mean± S.D 2, 4, 6, 8, 1, 12, 16, 2, 24 hr) and filtered. The required dilutions were made with and the solution was analyzed for the drug content by using UV detector detecting at λ max 239 nm 1 ml of sample was replaced in the vessel after each withdrawal to maintain sink condition. From this percentage drug release was calculated and this was plotted against function of time to study the pattern of drug release. The in-vitro drug release profiles of tablet from each batch (F1 to F1) were shown in Table 5. The plot of cumulative percentage drug release versus time (hr) was plotted and depicted as shown in Figure 1 and 2 Analysis of release mechanism In order to examine the release mechanism of Amlodipine besylate from the prepared floating tablets of the optimized formulation (F1), the results of the dissolution study was examined in accordance to the kinetic models. The regression coefficient R 2 value nearer to 1 indicated the model fitting of the release mechanism. The results are shown in Table 6 and Figure 3 to 6. Comparison with marketed product: The promising formulation (F1) as found by evaluation studies was compared with marketed product Amlosafe (Amlodipine besylate). The evaluation parameters tested and compared were drug content uniformity and in-vitro dissolution profile. The values of comparative in-vitro dissolution study of optimized formulation (F1) and marketed product are recorded in Table 7 and the result had come that the F1 formulation was sustained released as compare with Amlosafe tablet. Cumulative % Drug Released 12 1 Comparative Invitro Dissolution Drug Released F 1 Marketed Product Time (hrs) Figure 7: Plot of Comparative dissolution profile of optimized formulation (F1) and marked product RESULTS AND DISCUSSION: Amlodipine is a potent drug for the treatment of angina, hypertension and also suitable in the treatment diabetic hypertension. Amlodipine had maximum solubility in acidic ph. Amlodipine has some adverse effect such as headache, nausea, abdominal pain. Prolonged gastric retention improves bioavailability, reduces drug waste and improves solubility for drugs that are less soluble in high ph environment. Effervescence production, decrease the several local GIT side effect, such as gastric irritation, nausea and gastritis. The effervescent floating tablets of Amlodipine besylate were formulated in ten different batches F1 tof1 by using hydrophilic polymers HPMC K1M, HPMC K15M and hydrophobic polymer carbopol 934P along with effervescing agent sodium bicarbonate and citric acid. It was found that carbopol has a negative effect on floating behavior but it was used only for the drug release retardant characteristics. All the formulations were prepared by direct compression 528

4 method. The prepared tablets of all the formulations were evaluated for physical characters like tablet hardness, friability, weight variation buoyancy lag time, total floating time, assay, in-vitro drug release. The main aim was to optimize the formulation for 24 hours in-vitro release and total floating time to more than 24 hours. Table 3: Buoyancy Lag Time, Total Floating Time of formulations (F1toF1) Formulation Buoyancy Lag Total Floating Time (Sec) Time (hrs) F1 F2 F3 F4 F5 F6 F7 F8 F9 F1 133 sec 13 sec Fail 12 sec 12 sec 15sec 14sec 141sec 138sec 11sec >12 hrs >14 hrs Fail >16 hrs >16 hrs >2hrs >2hrs The measured hardness of tablets of each formulation ranged between 4.1 to 4.5 kg/cm 2. The % friability was less than 1% in all the formulations ensuring that the tablets were mechanically stable. All the tablets passed weight variation test as the % weight variation was within the Pharmacopoeial limits of ±5% of the weight. Buoyancy lag time (BLT) and total floating time (TFT) of different formulation were noted, where F1 BLT of 133 sec and TFT of >12 hours, F2 BLT of 13 sec and TFT of >14 hours, F3 fails to buoyancy because of absence of H P M C polymers, F4 BLT of 12sec and TFT of >16 hours, F5 BLT of 12 sec and TFT of >16 hours, F6 BLT of 15 sec and TFT of >2 hours, F7 BLT of 14 sec and TFT of >2 hours, F8 BLT of 141 sec and TFT of >24 hours, F9 BLT of 138 sec and TFT of >24 hours, F1 BLT of 11 sec and TFT of >24 hours, With reference to buoyancy studies results it can be concluded that the batch containing HPMC polymers showed good buoyancy lag time (BLT) and total floating time (TFT). Formulation F1 containing HPMC K15M, HPMC K1M and carbopol 934P showed good BLT of 11 sec and TFT of more than 24 hrs. Amlodipine besylate release from the effervescent floating tablets was studied in phosphate buffer ph 7.4. The release profile of various formulations are shown in table no. Figure no. 1 and 2. Formulation F1 released 98.4% of the drug in 12 hours. Formulation F2 released 98.4% of the drug in 16 hours. Formulation F3 released 96.2% of the drug in 8 hours. Formulation F4 released 98.3% of the drug in 16 hours Formulation F5 released 98.7% of the drug in 16 hours Formulation F6 released 98.4% of the drug in 16hours.Formulation F7 released 98.3% of the drug in 16 hours. Formulation F8 released Research J. Pharm. and Tech. 1(4): Oct.-Dec. 28, 98.8% of the drug in 2 hours. Formulation F9 released 98.4% of the drug in 2 hours. F1 released 98.6 % of drug in 24 hours. Thus F1 formulation was said to be optimized formulation. Table 4: Drug Content Uniformity of Tablets of Batch F1 to F1 Batches Drug content uniformity (%) F F F F F F F F F F Optimized formulation F1 was subjected to curve fitting analysis, zero order, and first order, Higuhi Kinetics, Korsmeyer and Peppas model. The slope and r 2 are shown in Table 6 and graphs in Figure 3 to 6. Optimized formulation F1 fitted best for Korsemeyer Peppas equation with R 2 value of Comparison study with marketed product of Amlodipine besylate1mg (Amlodipine 1) showed that the optimized formulation F1 has better control over release rate in comparison to the commercial product. The marketed product released the drug 98.3% in 12 hours whereas the optimized formulation F1 released the drug 72.1% in 12hrs. And the optimized formulation F1 remained floatable in the stomach for 24 hours.and give the maximum released 98.6 at 24 th hours. It is, thus concluded that effervescent floating tablet containing Amlodipine besylate (F1 formulation) gave slow and complete drug release spread over 24 hours. ACKNOWLEDGMENT: The authors are grateful to Centre for development action and community research (CDACR) for help in literature survey and procurement of drug sample. REFERENCES: 1. Deshpande AA, Shah NH, Rhodes CT and Malick W. Development of a novel controlled release system for gastric retention. Pharm. Res. 1997; 14(6): Klausner EA, Lavy E, Friedman M and Hoffman A. Expandable gastroretentive dosage form. J. Control. Rel. 23; 9: Singh BN and Kim HK. Floating drug delivery systems: an approach to oral controlled drug delivery via gastric retention. J. Control. Rel. 2; 63: Barar FSK. Essentials of pharmacotherapeutis.3 rd S. Chand and Company Ltd. New Delhi Gutierrez-rocca J, Omidian H and Shah K. Progress in Gastroretentive Drug Delivery System Bussiness Briefing, Pharmatech. 23:

5 Research J. Pharm. and Tech. 1(4): Oct.-Dec. 28, Table 5: In-vitro drug release profile of tablets of F1 to F1 Time Cumulative Percentage Drug Release (hr) F1 F2 F3 F4 F5 F6 F7 F8 F9 F Table 6: Kinetic Release Data of Different Model for Optimized Formulation (F1) Model Slope R 2 value Zero order First order Higuchi Korsemeyer-Peppas model Table 7: Comparative dissolution profile of optimized formulation (F1) and marketed product. Time (hr) Cumulative percentage drug release F1 Marketed product Hou SY, Cowles VE and Berner. Gastric Retentive Dosage Forms: A Review, Crit. Rev.Ther. Drug Carrier Syst. 23; 2(6): Aulton ME. Pharmaceutics: The Science of Dosage Form Design. 2 nd Ed. London: Churchill Livingstone Patil SB, Murthy RSR. Preparation and in vitro evaluation of mucoadhesive chitosan microspheres of amlodipine besylate for nasal administration. Iijpsonline. 28; July3:

Dual retard tablets of amlodipine besylate and atenolol

Dual retard tablets of amlodipine besylate and atenolol 10 Formulation, optimization and evaluation of dual retard tablet of amlodipine besylate and atenolol Hypertension, commonly referred to as high blood pressure, is a medical condition where the pressure

More information

8 Formulaton, evaluation and optimization of immediate release layer of amlodipine besylate

8 Formulaton, evaluation and optimization of immediate release layer of amlodipine besylate 8 Formulaton, evaluation and optimization of immediate release layer of amlodipine besylate Amlodipine besylate is antihypertensine and also used in angina. Conventional tablets are requiring to be administered

More information

SIMPLE U.V. SPECTROPHOTOMETRIC METHODS FOR THE ESTIMATION OF OFLOXACIN IN PHARMACEUTICAL FORMULATIONS

SIMPLE U.V. SPECTROPHOTOMETRIC METHODS FOR THE ESTIMATION OF OFLOXACIN IN PHARMACEUTICAL FORMULATIONS Int. J. Chem. Sci.: 8(2), 2010, 983-990 SIMPLE U.V. SPECTROPHOTOMETRIC METHODS FOR THE ESTIMATION OF OFLOXACIN IN PHARMACEUTICAL FORMULATIONS C. SOWMYA *, Y. PADMANABHA REDDY, J. RAVINDRA REDDY, M. SIVA

More information

Research and Reviews: Journal of Pharmacy and Pharmaceutical Sciences

Research and Reviews: Journal of Pharmacy and Pharmaceutical Sciences Research and Reviews: Journal of Pharmacy and Pharmaceutical Sciences Formulation and Evaluation of Matrix Tablets of Albendazole for Colon Site Specific Drug Delivery Prasanth VV 1, Jayaprakash R 2 *,

More information

DESIGN AND EVALUATION OF DRUG RELEASE KINETICS OF MELOXICAM SUSTAINED RELEASE MATRIX TABLETS

DESIGN AND EVALUATION OF DRUG RELEASE KINETICS OF MELOXICAM SUSTAINED RELEASE MATRIX TABLETS Academic Sciences International Journal of Current Pharmaceutical Research ISSN- 0975-7066 Vol 4, Issue 1, 2012 Research Article DESIGN AND EVALUATION OF DRUG RELEASE KINETICS OF MELOXICAM SUSTAINED RELEASE

More information

Formulation and evaluation of Gastro-retentive mucoadhesive Cefpodoxime Proxetil tablets

Formulation and evaluation of Gastro-retentive mucoadhesive Cefpodoxime Proxetil tablets 2015; 4(4): 20-25 ISSN: 2277-7695 TPI 2015; 4(4): 20-25 2015 TPI www.thepharmajournal.com Received: 12-04-2015 Accepted: 13-05-2015 Sunil kumar B Chandrashekar C Patil Mithun H Pramod Bagi Plant head,

More information

Development and validation of a HPLC analytical assay method for amlodipine besylate tablets: A Potent Ca +2 channel blocker

Development and validation of a HPLC analytical assay method for amlodipine besylate tablets: A Potent Ca +2 channel blocker Development and validation of a HPLC analytical assay method for amlodipine besylate tablets: A Potent Ca +2 channel blocker Richa Sah* and Saahil Arora 1. ISF College of Pharmacy, Moga, Punjab, India

More information

Release pattern of three new polymers in Ketoprofen controlled-release tablets

Release pattern of three new polymers in Ketoprofen controlled-release tablets African Journal of Pharmacy and Pharmacology Vol. 6(9), pp. 601-607, 8 March, 2012 Available online at http://www.academicjournals.org/ajpp DOI: 10.5897/AJPP11.604 ISSN 1996-0816 2012 Academic Journals

More information

FORMULATION AND EVALUATION OF S-(-)-AMLODIPINE BESYLATE AND NEBIVOLOL HYDROCHLORIDE TABLETS

FORMULATION AND EVALUATION OF S-(-)-AMLODIPINE BESYLATE AND NEBIVOLOL HYDROCHLORIDE TABLETS Digest Journal of Nanomaterials and Biostructures Vol. 5, No 1, March 2010, p. 201 205 FORMULATION AND EVALUATION OF S-(-)-AMLODIPINE BESYLATE AND NEBIVOLOL HYDROCHLORIDE TABLETS S. A. SHAIKH *, S. S.

More information

VALIDATED RP-HPLC METHOD FOR THE SIMULTANEOUS DETERMINATION OF AMLODIPINE BESYLATE AND ATORVASTATIN CALCIUM IN BULK AND PHARMACEUTICAL FORMULATION

VALIDATED RP-HPLC METHOD FOR THE SIMULTANEOUS DETERMINATION OF AMLODIPINE BESYLATE AND ATORVASTATIN CALCIUM IN BULK AND PHARMACEUTICAL FORMULATION INTERNATIONAL JOURNAL OF RESEARCH IN PHARMACY AND CHEMISTRY Available online at www.ijrpc.com Research Article VALIDATED RP-HPLC METHOD FOR THE SIMULTANEOUS DETERMINATION OF AMLODIPINE BESYLATE AND ATORVASTATIN

More information

SPECTROPHOTOMETRIC ESTIMATION OF MELOXICAM IN BULK AND ITS PHARMACEUTICAL FORMULATIONS

SPECTROPHOTOMETRIC ESTIMATION OF MELOXICAM IN BULK AND ITS PHARMACEUTICAL FORMULATIONS SPECTROPHOTOMETRIC ESTIMATION OF MELOXICAM IN BULK AND ITS PHARMACEUTICAL FORMULATIONS B.DHANDAPANI, S.ESWARA MURALI, N. SUSRUTHA, RAMA SWETHA, S K. SONIA RANI, T. SARATH BABU, G.V. SEETHARAMANJANEYULU,

More information

Deptt of Pharma Science SGRR ITS Patel Nagar, Dehradun (UK)

Deptt of Pharma Science SGRR ITS Patel Nagar, Dehradun (UK) METHOD DEVELOPMENT AND ITS VALIDATION FOR SIMULTANEOUS ESTIMATION OF ATORVASTATIN AND AMLODIPINE IN COMBINATION IN TABLET DOSAGE FORM BY UV SPECTROSCOPY, USING MULTI-COMPONENT MODE OF ANALYSIS V. Juyal

More information

Tamboli Ashpak Mubarak et al. IRJP 2 (8)

Tamboli Ashpak Mubarak et al. IRJP 2 (8) INTERNATIONAL RESEARCH JOURNAL OF PHARMACY ISSN 2230 8407 Available online http://www.irjponline.com Research Article DEVELOPMENT AND VALIDATION OF STABILITY INDICATING HPLC METHOD FOR SIMULTANEOUS DETERMINATION

More information

INTERNATIONAL RESEARCH JOURNAL OF PHARMACY

INTERNATIONAL RESEARCH JOURNAL OF PHARMACY INTERNATIONAL RESEARCH JOURNAL OF PHARMACY www.irjponline.com ISSN 2230 8407 Research Article FORMULATION AND EVALUATION OF FAST DISSOLVING TABLETS OF OFLOXACIN BY DIRECT COMPRESSION METHOD Shivaramakrishna

More information

Pharma Research Library. 2013, Vol. 1(1):19-29

Pharma Research Library. 2013, Vol. 1(1):19-29 Available online at www.pharmaresearchlibrary.com Pharma Research Library International Journal of Current Trends in Pharmaceutical Research 2013, Vol. 1(1):19-29 Pharma Research Library Method development

More information

International Journal of Drug Delivery 4 (2012) Original Research Article

International Journal of Drug Delivery 4 (2012) Original Research Article International Journal of Drug Delivery 4 (2012) 366-374 http://www.arjournals.org/index.php/ijdd/index Original Research Article ISSN: 0975-0215 Control the drug release of Levofloxacin by using different

More information

Spectrophotometric Method for Simultaneous Estimation of Amlodipine Besylate in Pharmaceutical Formulation

Spectrophotometric Method for Simultaneous Estimation of Amlodipine Besylate in Pharmaceutical Formulation Spectrophotometric Method for Simultaneous Estimation of Amlodipine Besylate in Pharmaceutical Formulation Naresh Kalra*, Suresh Choudhary Department of Pharmaceutical sciences, Alwar Pharmacy College,

More information

DEVELOPMENT AND VALIDATION OF RP-HPLC METHOD FOR SIMULTANEOUS ESTIMATION OF AMLODIPINE BESYLATE AND IRBESARTAN

DEVELOPMENT AND VALIDATION OF RP-HPLC METHOD FOR SIMULTANEOUS ESTIMATION OF AMLODIPINE BESYLATE AND IRBESARTAN Indexed in Cite Factor - Directory of International Research Journals in association with leading Universities DEVELOPMENT AND VALIDATION OF RP-HPLC METHOD FOR SIMULTANEOUS ESTIMATION OF AMLODIPINE BESYLATE

More information

PO. Vasan, Gandhinagar District, Gujarat, India, 3 Dean at Faculty of Pharmacy, Dharmsinh Desai University, Nadiad, Gujarat, India.

PO. Vasan, Gandhinagar District, Gujarat, India, 3 Dean at Faculty of Pharmacy, Dharmsinh Desai University, Nadiad, Gujarat, India. International Journal of ChemTech Research CODEN (USA): IJCRGG ISSN : 0974-4290 Vol.6, No.5, pp 2615-2619, Aug-Sept 2014 Development and Validation of Simultaneous Estimation of Cefpodoxime proxetil and

More information

Should you have any questions, please contact Edith Chang, Ph.D., Senior Scientific Liaison ( or

Should you have any questions, please contact Edith Chang, Ph.D., Senior Scientific Liaison ( or Amlodipine and Tablets Type of Posting Posting Date Targeted Official Date Notice of Intent to Revise 26 Oct 2018 To Be Determined, Revision Bulletin Expert Committee Chemical Medicines Monographs 2 In

More information

DEVELOPMENT AND VALIDATION OF RP-HPLC METHOD FOR THE SIMULTANEOUS ESTIMATION OF ALISKIREN AND AMLODIPINE IN TABLET DOSAGE FORM

DEVELOPMENT AND VALIDATION OF RP-HPLC METHOD FOR THE SIMULTANEOUS ESTIMATION OF ALISKIREN AND AMLODIPINE IN TABLET DOSAGE FORM Page288 Research Article Pharmaceutical Sciences DEVELOPMENT AND VALIDATION OF RP-HPLC METHOD FOR THE SIMULTANEOUS ESTIMATION OF ALISKIREN AND AMLODIPINE IN TABLET DOSAGE FORM Divya P, Aleti P, Venisetty

More information

International Journal of Pharmaceutical Research & Analysis

International Journal of Pharmaceutical Research & Analysis 13 International Journal of Pharmaceutical Research & Analysis e-issn: 2249 7781 Print ISSN: 2249 779X www.ijpra.com RP-HPLC METHOD DEVELOPMENT AND VALIDATION FOR SIMULTANEOUS ESTIMATION OF AMLODIPINE

More information

INTERNATIONAL JOURNAL OF PHARMACEUTICAL RESEARCH AND BIO-SCIENCE

INTERNATIONAL JOURNAL OF PHARMACEUTICAL RESEARCH AND BIO-SCIENCE RESEARCH ARTICLE INTERNATIONAL JOURNAL OF PHARMACEUTICAL RESEARCH AND BIO-SCIENCE A Path for Horizing Your Innovative Work METHOD DEVLOPMENT AND VALIDATION OF CEFIXIME AND MOXIFLOXACIN IN PHARMACEUTICAL

More information

Development and Validation of UV Spectrophotometric Area Under Curve (AUC) method for estimation of Pyrantel Pamoate in Bulk and Tablet Dosage Form

Development and Validation of UV Spectrophotometric Area Under Curve (AUC) method for estimation of Pyrantel Pamoate in Bulk and Tablet Dosage Form International Journal of Interdisciplinary and Multidisciplinary Studies (IJIMS), 2014, Vol 1, No.7, 70-76. 70 Available online at http://www.ijims.com ISSN: 2348 0343 Development and Validation of UV

More information

AMOXICILLIN AND CLAVULANIC ACID TABLETS Draft proposal for The International Pharmacopoeia (February 2018)

AMOXICILLIN AND CLAVULANIC ACID TABLETS Draft proposal for The International Pharmacopoeia (February 2018) February 2018 Draft for comment 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 AMOXICILLIN AND CLAVULANIC ACID TABLETS Draft

More information

Kamepalli Sujana et al. / Journal of Pharmacy Research 2014,8(12), Available online through

Kamepalli Sujana et al. / Journal of Pharmacy Research 2014,8(12), Available online through Research Article ISSN: 0974-6943 Available online through www.jpronline.info Simultaneous equation method for the estimation of Atorvastatin calcium and Amlodipine besylate in bulk and in combined tablet

More information

Isocratic Reverse Phase High Performance Liquid Chromatographic Estimation of Ramipril and Amlodipine in Pharmaceutical Dosage Form

Isocratic Reverse Phase High Performance Liquid Chromatographic Estimation of Ramipril and Amlodipine in Pharmaceutical Dosage Form Isocratic Reverse Phase High Performance Liquid Chromatographic Estimation of Ramipril and Amlodipine in Pharmaceutical Dosage Form Manikanta Kumar. A, P. Vijay Kumar *, Mahesh Nasare, Venkateswar Rao,

More information

ABSTRACT. Usharani N, Divya K and Ashrtiha VVS. Original Article

ABSTRACT. Usharani N, Divya K and Ashrtiha VVS. Original Article Original Article Development and Validation of UV-Derivative Spectroscopic and RP-HPLC Methods for the Determination of Amlodipine Besylate and Valsartan in Tablet Dosage form and Comparison of the Developed

More information

Asian Journal of Research in Biological and Pharmaceutical Sciences Journal home page:

Asian Journal of Research in Biological and Pharmaceutical Sciences Journal home page: Research Article ISSN: 2349 4492 Asian Journal of Research in Biological and Pharmaceutical Sciences Journal home page: www.ajrbps.com FORMULATION AND EVALUATION OF ORODISPERSIBLE LIQUISOLID COMPACTS OF

More information

Formulation, Development & Characterization of Ofloxacin Microspheres

Formulation, Development & Characterization of Ofloxacin Microspheres Formulation, Development & Characterization of Ofloxacin Microspheres Vidhyaa Kumari a, Vignesh Muruganandham b* a School of Pharmacy & Applied Science, La Trobe University, Bendigo, Victoria 3552, Australia

More information

INTERNATIONAL JOURNAL OF INSTITUTIONAL PHARMACY AND LIFE SCIENCES

INTERNATIONAL JOURNAL OF INSTITUTIONAL PHARMACY AND LIFE SCIENCES International Standard Serial Number (ISSN): 2249-687 International Journal of Institutional Pharmacy and Life Sciences 5(2): March-April 215 INTERNATIONAL JOURNAL OF INSTITUTIONAL PHARMACY AND LIFE SCIENCES

More information

Moxifloxacin (as hydrochloride) 400 mg Tablets WHOPAR part 6 November 2017 (Hetero Labs Limited), TB 315

Moxifloxacin (as hydrochloride) 400 mg Tablets WHOPAR part 6 November 2017 (Hetero Labs Limited), TB 315 This part reflects the scientific knowledge and the information about this product available at the time of prequalification. Thereafter, updates may have become necessary which are included in parts 1

More information

Determination of Amlodipine in Rat Plasma by UV Spectroscopy

Determination of Amlodipine in Rat Plasma by UV Spectroscopy Determination of Amlodipine in Rat Plasma by UV Spectroscopy P. Srinivasulu 1*, B.K. Gowthami 2, T.N.V. Ganesh Kumar 1, D. Surya Narayana Raju 1, S. Vidyadhara 1 1 Chebrolu Hanumaiah Institute of Pharmaceutical

More information

Development and validation of HPLC method for simultaneous estimation of Amlodipine besylate and Enalapril maleate in solid dosage form

Development and validation of HPLC method for simultaneous estimation of Amlodipine besylate and Enalapril maleate in solid dosage form World Journal of Pharmaceutical Sciences ISS (Print): 2321-3310; ISS (nline): 2321-3086 Published by Atom and Cell Publishers All Rights Reserved Available online at: http://www.wjpsonline.org/ riginal

More information

Compliance. Should you have any questions, please contact Praveen Pabba, Ph.D., ( or

Compliance. Should you have any questions, please contact Praveen Pabba, Ph.D., ( or Doxycycline Hyclate Delayed-Release Tablets Type of Posting Revision Bulletin Posting Date 28 Jul 2017 Official Date 01 Aug 2017 Expert Committee Chemical Medicines Monographs 1 Reason for Revision Compliance

More information

Journal of Global Trends in Pharmaceutical Sciences

Journal of Global Trends in Pharmaceutical Sciences An Elsevier Indexed Journal ISSN-2230-7346 Journal of Global Trends in Pharmaceutical Sciences A NEW IMPROVED RP-HPLC METHOD FOR SIMULTANEOUS ESTIMATION OF HYDROCHLOROTHIAZIDE, AMLODIPINE BESYLATE AND

More information

IN VITRO STUDIES OF AMLODIPINE BESYLATE TABLET AND COMPARISON WITH FOREIGN BRAND LEADER IN NEPAL

IN VITRO STUDIES OF AMLODIPINE BESYLATE TABLET AND COMPARISON WITH FOREIGN BRAND LEADER IN NEPAL IJPSR (2013), Vol. 4, Issue 10 (Research Article) Received on 24 May, 2013; received in revised form, 30 July, 2013; accepted, 24 September, 2013; published 01 October, 2013 IN VITRO STUDIES OF AMLODIPINE

More information

International Journal of Advances in Pharmacy and Biotechnology Vol.3, Issue-2, 2017, 1-7 Research Article Open Access.

International Journal of Advances in Pharmacy and Biotechnology Vol.3, Issue-2, 2017, 1-7 Research Article Open Access. I J A P B International Journal of Advances in Pharmacy and Biotechnology Vol.3, Issue-2, 2017, 1-7 Research Article Open Access. ISSN: 2454-8375 COMPARISON OF ANTIMICROBIAL ACTIVITY AND MIC OF BRANDED

More information

single intravenous and oral doses and after 14 repeated oral

single intravenous and oral doses and after 14 repeated oral Br. J. clin. Pharmac. (1986), 22, 21-25 The pharmacokinetics of amlodipine in healthy volunteers after single intravenous and oral doses and after 14 repeated oral doses given once daily J. K. FAULKNER

More information

Publication Ref No.: IJPRD/2010/PUB/ARTI/VOV-2/ISSUE-5/JULY/013 ISSN

Publication Ref No.: IJPRD/2010/PUB/ARTI/VOV-2/ISSUE-5/JULY/013 ISSN SIMULTANEOUS ESTIMATION OF NEBIVOLOL HYDROCHLORIDE AND AMLODIPINE BESYLATE IN COMBINED TABLET DOSAGE FORM BY Q-ANALYSIS METHOD Chandan Kumar Giri 1 *, M.S. Kondawar and D.D. Chougule 1 Chandan Kumar 1

More information

Amlodipine, Valsartan, and Hydrochlorothiazide Tablets

Amlodipine, Valsartan, and Hydrochlorothiazide Tablets . Table Interim Revision Announcement Official November 1, 2017 Amlodipine 1 Amlodipine, Valsartan, and Hydrochlorothiazide Tablets 2 (Continued) Tablet Strength Nominal Amlodipine/ Nominal Concentra-

More information

Determination of ofloxacin in bulk drug and pharmaceutical dosage form by high performance liquid chromatography method

Determination of ofloxacin in bulk drug and pharmaceutical dosage form by high performance liquid chromatography method Available online at www.scholarsresearchlibrary.com Scholars Research Library Der Pharmacia Lettre, 2015, 7 (10):188-192 (http://scholarsresearchlibrary.com/archive.html) ISSN 0975-5071 USA CODEN: DPLEB4

More information

PATIENT INFORMATION LEAFLET DYNA CEFPODOXIME 100 mg / DYNA CEFPODOXIME SUSPENSION:

PATIENT INFORMATION LEAFLET DYNA CEFPODOXIME 100 mg / DYNA CEFPODOXIME SUSPENSION: SCHEDULING STATUS S4 PROPRIETARY NAME, STRENGTH AND PHARMACEUTICAL FORM: DYNA CEFPODOXIME 100 mg (film coated tablet) DYNA CEFPODOXIME SUSPENSION (powder for oral suspension) Please read this leaflet carefully

More information

Synopsis. Takeda Pharmaceutical Company Limited Name of the finished product UNISIA Combination Tablets LD, UNISIA Combination Tablets

Synopsis. Takeda Pharmaceutical Company Limited Name of the finished product UNISIA Combination Tablets LD, UNISIA Combination Tablets Synopsis Name of the sponsor Takeda Pharmaceutical Company Limited Name of the finished product UNISIA Combination Tablets LD, UNISIA Combination Tablets Name of active ingredient Title of the study Study

More information

New Zealand Consumer Medicine Information

New Zealand Consumer Medicine Information New Zealand Consumer Medicine Information FLUCLOXACILLIN Flucloxacillin (as the sodium salt) 250 mg and 500 mg capsules Flucloxacillin (as the sodium salt) 125 mg/5 ml and 250 mg/5 ml powder for oral solution

More information

A Simple Sample Preparation with HPLC UV Method for Estimation of Amlodipine from Plasma: Application to Bioequivalence Study

A Simple Sample Preparation with HPLC UV Method for Estimation of Amlodipine from Plasma: Application to Bioequivalence Study 22 The Open Chemical and Biomedical Methods Journal, 2008, 1, 22-27 Open Access A Simple Sample Preparation with HPLC UV Method for Estimation of Amlodipine from Plasma: Application to Bioequivalence Study

More information

Available online International Journal of Pharmaceutical Research & Allied Sciences, 2016, 5(4):37-44.

Available online  International Journal of Pharmaceutical Research & Allied Sciences, 2016, 5(4):37-44. Available online www.ijpras.com International Journal of Pharmaceutical Research & Allied Sciences, 2016, 5(4):37-44 Research Article ISSN : 2277-3657 CODEN(USA) : IJPRPM DEVELOPMENT AND VALIDATION OF

More information

AMLODIPINE GENERICHEALTH

AMLODIPINE GENERICHEALTH AMLODIPINE GENERICHEALTH Consumer Medicine Information What is in this leaflet This leaflet answers some common questions about Amlodipine generichealth. It does not contain all the available information.

More information

Keywords: Derivative spectrophotometry, Telmisartan, Hydrochlorthiazide, Amlodipine ABSTRACT

Keywords: Derivative spectrophotometry, Telmisartan, Hydrochlorthiazide, Amlodipine ABSTRACT Human Journals Research Article August 2015 Vol.:4, Issue:1 All rights are reserved by Manish A. Raskar et al. Validated Simultaneous Derivative Spectrophotometric Estimation of Telmisartan, Hydrochlorthiazide

More information

SZENT ISTVÁN UNIVERSITY. Doctoral School of Veterinary Science

SZENT ISTVÁN UNIVERSITY. Doctoral School of Veterinary Science SZENT ISTVÁN UNIVERSITY Doctoral School of Veterinary Science Comparative pharmacokinetics of the amoxicillinclavulanic acid combination in broiler chickens and turkeys, susceptibility and stability tests

More information

C 22 H 28 FNa 2 O 8 Pıı516.4

C 22 H 28 FNa 2 O 8 Pıı516.4 SIMULTANEOUS DETERMINATION OF DEXAMETHASONE SODIUM PHOSPHATE AND CHLORAMPHENICOL IN OPHTHALMIC SOLUTIONS W.A. Shadoul, E.A. Gad Kariem, M.E. Adam, K.E.E. Ibrahim* Department of Pharmaceutical Chemistry,

More information

Providing Constant Analgesia with OROS Ò Hydromorphone

Providing Constant Analgesia with OROS Ò Hydromorphone Vol. 33 No. 2S February 2007 Journal of Pain and Symptom Management S19 Advances in the Long-Term Management of Chronic Pain: Recent Evidence with OROS Ò Hydromorphone, a Novel, Once-Daily, Long-Acting

More information

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 1 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Credelio 56 mg chewable tablets for dogs (1.3 2.5 kg) Credelio 112 mg chewable tablets for dogs (>2.5 5.5 kg) Credelio

More information

Public Assessment Report. Scientific discussion. Xiflodrop 5 mg/ml eye drops, solution. Moxifloxacin hydrochloride DK/H/2221/001/DC

Public Assessment Report. Scientific discussion. Xiflodrop 5 mg/ml eye drops, solution. Moxifloxacin hydrochloride DK/H/2221/001/DC Public Assessment Report Scientific discussion Xiflodrop 5 mg/ml eye drops, solution Moxifloxacin hydrochloride DK/H/2221/001/DC This module reflects the scientific discussion for the approval of Xiflodrop.

More information

METHOD DEVELOPMENT AND VALIDATION FOR THE SIMULTANEOUS ESTIMATION OF OFLOXACIN AND ORNIDAZOLE IN TABLET DOSAGE FORM BY RP-HPLC

METHOD DEVELOPMENT AND VALIDATION FOR THE SIMULTANEOUS ESTIMATION OF OFLOXACIN AND ORNIDAZOLE IN TABLET DOSAGE FORM BY RP-HPLC METHOD DEVELOPMENT AND VALIDATION FOR THE SIMULTANEOUS ESTIMATION OF OFLOXACIN AND ORNIDAZOLE IN TABLET DOSAGE FORM BY RP-HPLC B.Dhandapani *1, N.Thirumoorthy 2, Shaik Harun Rasheed 3, M.Rama kotaiah 3

More information

Summary of product characteristics As per Annex C. SUMMARY OF PRODUCT CHARACTERISTICS Doc. No. SPC/71108 Ver.1

Summary of product characteristics As per Annex C. SUMMARY OF PRODUCT CHARACTERISTICS Doc. No. SPC/71108 Ver.1 Summary of product characteristics As per Annex C SUMMARY OF PRODUCT CHARACTERISTICS Doc. No. SPC/71108 Ver.1 1. NAME OF THE MEDICINAL PRODUCT. ANNEXURE C to MODULE I Tetanus vaccine (Adsorbed) I.P. 2.

More information

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS. Medicinal product no longer authorised

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS. Medicinal product no longer authorised ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 1 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Zubrin 50 mg oral lyophilisates for dogs Zubrin 100 mg oral lyophilisates for dogs Zubrin 200 mg oral lyophilisates

More information

Development and Validation of Amlodipine Impurities in Amlodipine Tablets Using Design Space Computer Modeling

Development and Validation of Amlodipine Impurities in Amlodipine Tablets Using Design Space Computer Modeling American Journal of Analytical Chemistry, 2016, 7, 918-926 http://www.scirp.org/journal/ajac ISSN Online: 2156-8278 ISSN Print: 2156-8251 Development and Validation of Amlodipine Impurities in Amlodipine

More information

ENHANCEMENT OF DISSOLUTION AND ANTI INFLAMMATORY EFFECT OF MELOXICAM USING SOLID DISPERSIONS

ENHANCEMENT OF DISSOLUTION AND ANTI INFLAMMATORY EFFECT OF MELOXICAM USING SOLID DISPERSIONS International Journal of Applied Pharmaceutics Vol 2 Issue 1, 2 Research Article ENHANCEMENT OF DISSOLUTION AND ANTI INFLAMMATORY EFFECT OF MELOXICAM USING SOLID DISPERSIONS MOHAMMED JAFAR 1*, DEHGHAN

More information

Catalogue. August 2014 PRODUCT GUIDE

Catalogue. August 2014 PRODUCT GUIDE August 2014 Catalogue PRODUCT GUIDE KENT Marine is committed to providing effective ways to keep beautiful, healthy aquariums. For over 15 years, we have been offering solutions that help the hobbyist

More information

FORMULATION AND EVALUATION OF TOPICAL GEL OF MELOXICAM

FORMULATION AND EVALUATION OF TOPICAL GEL OF MELOXICAM INTERNATIONAL JOURNAL OF RESEARCH IN PHARMACY AND CHEMISTRY Available online at www.ijrpc.com Research Article FORMULATION AND EVALUATION OF TOPICAL GEL OF MELOXICAM Loveleenpreet kaur 1* and Prabhjot

More information

SUMMARY OF PRODUCT CHARACTERISTICS

SUMMARY OF PRODUCT CHARACTERISTICS SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE VETERINARY MEDICINAL PRODUCT RONAXAN 20mg Tablet 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each tablet contains: Active substance : Doxycycline (as doxycycline

More information

Just where it s needed.

Just where it s needed. Relief. Just where it s needed. Tissue-selective 7,8 Strong safety profile 5,6,10,11 For dogs and cats Onsior is available in a range of convenient and easy-to-dose formulations. Injectable solution for

More information

PACKAGE LEAFLET Page 1 of 6

PACKAGE LEAFLET Page 1 of 6 PACKAGE LEAFLET Page 1 of 6 Package leaflet: Information for the patient Desloratadine Mylan 5 mg film-coated tablets desloratadine Read all of this leaflet carefully before you start taking this medicine

More information

Dosing Your Cat with Azithromycin Pediatric Suspension. By Lorraine Shelton

Dosing Your Cat with Azithromycin Pediatric Suspension. By Lorraine Shelton Dosing Your Cat with Azithromycin Pediatric Suspension By Lorraine Shelton To join a community of cat fanciers and health professionals interested in cattery related health issues, visit http://groups.yahoo.com/group/fanciershealth

More information

Amlodipin Bluefish 10 mg tablets. amlodipine

Amlodipin Bluefish 10 mg tablets. amlodipine Package leaflet: Information for the user Amlodipin Bluefish 5 mg tablets Amlodipin Bluefish 10 mg tablets amlodipine Read all of this leaflet carefully before you start taking this medicine because it

More information

SUMMARY OF PRODUCT CHARACTERISTICS

SUMMARY OF PRODUCT CHARACTERISTICS SUMMARY OF PRODUCT CHARACTERISTICS Revised: March 2015 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Tolracol 50 mg/ml oral suspension for pigs, cattle and sheep 2. QUALITATIVE AND QUANTITATIVE COMPOSITION

More information

United Kingdom Veterinary Medicines Directorate Woodham Lane New Haw Addlestone Surrey KT15 3LS MUTUAL RECOGNITION PROCEDURE

United Kingdom Veterinary Medicines Directorate Woodham Lane New Haw Addlestone Surrey KT15 3LS MUTUAL RECOGNITION PROCEDURE United Kingdom Veterinary Medicines Directorate Woodham Lane New Haw Addlestone Surrey KT15 3LS MUTUAL RECOGNITION PROCEDURE PUBLICLY AVAILABLE ASSESSMENT REPORT FOR A VETERINARY MEDICINAL PRODUCT Clavudale

More information

Joint Health Supplement

Joint Health Supplement Joint Health Supplement A Pet Owner s Guide to Joint Health for Dogs What is Cosequin? Cosequin is a patented, scientifically researched nutritional supplement dispensed by thousands of veterinarians for

More information

DETERMINATION OF ACTIVE SUBSTANCES IN MULTICOMPONENT VETERINARY PREPARATIONS OF ANTIPARASITIC ACTION BY HPLC METHOD

DETERMINATION OF ACTIVE SUBSTANCES IN MULTICOMPONENT VETERINARY PREPARATIONS OF ANTIPARASITIC ACTION BY HPLC METHOD Acta Poloniae Pharmaceutica ñ Drug Research, Vol. 67 No. 5 pp. 463ñ468, 2010 ISSN 0001-6837 Polish Pharmaceutical Society DETERMINATION OF ACTIVE SUBSTANCES IN MULTICOMPONENT VETERINARY PREPARATIONS OF

More information

Original Article. Abstract INTRODUCTION

Original Article. Abstract INTRODUCTION Original Article Simultaneous estimation of amlodipine besylate and nebivolol hydrochloride in tablet dosage forms by reverse phase-highperformance liquid chromatographic using ultraviolet detection Abstract

More information

The Institutional Animal Care and Use Committee (IACUC) Aquatic Animals: Analgesia and Anesthesia formulary

The Institutional Animal Care and Use Committee (IACUC) Aquatic Animals: Analgesia and Anesthesia formulary The Institutional Animal Care and Use Committee (IACUC) Aquatic Animals: Analgesia and Anesthesia formulary The appropriate use of pain medications (analgesics) and anesthetics is a critical aspect of

More information

A Pet Owner s Guide to Joint Health for Dogs

A Pet Owner s Guide to Joint Health for Dogs A Pet Owner s Guide to Joint Health for Dogs What is Cosequin? Cosequin is a patented, scientifically researched nutritional supplement dispensed by thousands of veterinarians since 1992 to help dogs maintain

More information

PACKAGE LEAFLET: INFORMATION FOR THE USER. Amlodipine 5 mg Tablets Amlodipine 10 mg Tablets (Amlodipine Besilate)

PACKAGE LEAFLET: INFORMATION FOR THE USER. Amlodipine 5 mg Tablets Amlodipine 10 mg Tablets (Amlodipine Besilate) PACKAGE LEAFLET: INFORMATION FOR THE USER Amlodipine 5 mg Tablets Amlodipine 10 mg Tablets (Amlodipine Besilate) Read all of this leaflet carefully before you start taking this medicine. - Keep this leaflet.

More information

College ter Beoordeling van Geneesmiddelen / Medicines Evaluation Board. Graadt van Roggenweg AH Utrecht The Netherlands

College ter Beoordeling van Geneesmiddelen / Medicines Evaluation Board. Graadt van Roggenweg AH Utrecht The Netherlands College ter Beoordeling van Geneesmiddelen / Medicines Evaluation Board Graadt van Roggenweg 500 3531 AH Utrecht The Netherlands MUTUAL RECOGNITION PROCEDURE PUBLICLY AVAILABLE ASSESSMENT REPORT FOR A

More information

PBPK/PD Modeling and Simulations to Guide Dose Recommendation of Amlodipine with Viekirax or Viekira Pak

PBPK/PD Modeling and Simulations to Guide Dose Recommendation of Amlodipine with Viekirax or Viekira Pak PBPK/PD Modeling and Simulations to Guide Dose Recommendation of Amlodipine with Viekirax or Viekira Pak Dwaipayan Mukherjee, Ph.D. Jiuhong Zha, Ph.D. Rajeev Menon, Ph.D. Mohamad Shebley, Ph.D. Clinical

More information

SUMMARY OF THE PRODUCT CHARACTERISTICS

SUMMARY OF THE PRODUCT CHARACTERISTICS 1 SUMMARY OF THE PRODUCT CHARACTERISTICS 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Exflow 10 mg/g powder for use in drinking water for cattle (calves), pigs, chickens, turkeys and ducks Exflow Vet 10

More information

Quantification of Albendazole in Dewormer Formulations in the Kenyan market

Quantification of Albendazole in Dewormer Formulations in the Kenyan market Available online at www.pelagiaresearchlibrary.com Advances in Applied Science Research, 2011, 2 (2): 9-13 Quantification of Albendazole in Dewormer Formulations in the Kenyan market H.N. Wanyika*, P G

More information

INTERNATIONAL RESEARCH JOURNAL OF PHARMACY

INTERNATIONAL RESEARCH JOURNAL OF PHARMACY INTERNATIONAL RESEARCH JOURNAL OF PHARMACY www.irjponline.com ISSN 2230 8407 Research Article DEVELOPMENT AND VALIDATION OF RP-HPLC METHOD FOR THE SIMULTANEOUS ESTIMATION OF AMLODIPINE AND HYDROCHLOROTHIAZIDE

More information

AMLODIPINE 5 MG TABLETS AMLODIPINE 10 MG TABLETS Amlodipine

AMLODIPINE 5 MG TABLETS AMLODIPINE 10 MG TABLETS Amlodipine Package Leaflet: Information For The User AMLODIPINE 5 MG TABLETS AMLODIPINE 10 MG TABLETS Amlodipine Read all of this leaflet carefully before you start taking this medicine because it contains important

More information

Don t let arthritis slow down your dog!

Don t let arthritis slow down your dog! Don t let arthritis slow down your dog! abcd DOG CAT ACUTE CHRONIC PERIOPERATIVE INJECTABLE ORAL SUSPENSION CHEWABLE Keeping your dog in the prime of life Is your dog at risk of developing arthritis? As

More information

Oral and intestinal candidiasis. As adjuvant treatment with other local nystatin preparations to prevent reinfection.

Oral and intestinal candidiasis. As adjuvant treatment with other local nystatin preparations to prevent reinfection. 1. NAME OF THE MEDICINAL PRODUCT Nystatin Orifarm, 100 000 IU/ml oral suspension 2. QUALITATIVE AND QUANTITATIVE COMPOSITION 1 ml contains 100 000 IU nystatin. Excipients with known effect: - Methyl parahydroxybenzoate

More information

SIMULTANEOUS UV-SPECTROPHOTOMETRIC DETERMINATION OF AMLODIPINE BESYLATE AND NEBIVOLOL HYDROCHLORIDE IN TABLET DOSAGE FORM

SIMULTANEOUS UV-SPECTROPHOTOMETRIC DETERMINATION OF AMLODIPINE BESYLATE AND NEBIVOLOL HYDROCHLORIDE IN TABLET DOSAGE FORM International Journal of ChemTech Research CODEN( USA): IJCRGG ISSN : 09744290 Vol.2, No.1, pp 6973, JanMar 2010 SIMULTANEOUS UVSPECTROPHOTOMETRIC DETERMINATION OF AMLODIPINE BESYLATE AND NEBIVOLOL HYDROCHLORIDE

More information

PATIENT INFORMATION LEAFLET

PATIENT INFORMATION LEAFLET PATIENT INFORMATION LEAFLET AMLOTAN 5mg TABLETS AMLOTAN 10mg TABLETS Amlodipine (as mesilate monohydrate) Read all of this leaflet carefully before you start taking this medicine. - Keep this leaflet.

More information

Stability Indicating Spectrophotometric Method of Amlodipine and Telmisartan in Bulk and Pharmaceutical Dosage Form

Stability Indicating Spectrophotometric Method of Amlodipine and Telmisartan in Bulk and Pharmaceutical Dosage Form Research Article Shinde Prasad S.* 1, Patil Pallavi M. 1 P.E.S s Modern College of Pharmacy, Sector 21, Yamunanagar, igdi, Pune-411044, Maharashtra, India. *Corresponding author s E-mail: pallavipatil_2007@yahoo.com

More information

Application of hydrotropic solubilization technique for simultaneous estimation and validation of ofloxacin and ornidazole in tablet dosage form

Application of hydrotropic solubilization technique for simultaneous estimation and validation of ofloxacin and ornidazole in tablet dosage form Available online at www.scholarsresearchlibrary.com Scholars Research Library Der Pharmacia Lettre, 2015, 7 (11):234-240 (http://scholarsresearchlibrary.com/archive.html) ISSN 0975-5071 USA CODEN: DPLEB4

More information

Chandra Mohan Rao Kota et al INTERNATIONAL JOURNAL OF RESEARCH AND REVIEWS IN PHARMACY AND APPLIED SCIENCES

Chandra Mohan Rao Kota et al INTERNATIONAL JOURNAL OF RESEARCH AND REVIEWS IN PHARMACY AND APPLIED SCIENCES Research Article Chandra Mohan Rao Kota et al I S S N 2249-1236 VOL 1, ISSUE (2) INTERNATIONAL JOURNAL OF RESEARCH AND REVIEWS IN PHARMACY AND APPLIED SCIENCES A SIMPLE GRADIENT RP-HPLC METHOD FOR THE

More information

RP-HPLC Method for Simultaneous Estimation of Enalapril Maleate and Chlorthalidone in Synthetic Mixture

RP-HPLC Method for Simultaneous Estimation of Enalapril Maleate and Chlorthalidone in Synthetic Mixture RP-HPLC Method for Simultaneous Estimation of Enalapril Maleate and in Synthetic Mixture VISHWA M. DAVE 1, Dr. DILIP G. MAHESHWARI *. *Head of Department, Department of Quality Assurance, L. J. Institute

More information

Public Assessment Report Scientific discussion. Amlodipin Accord (amlodipine besilate)

Public Assessment Report Scientific discussion. Amlodipin Accord (amlodipine besilate) Public Assessment Report Scientific discussion Amlodipin Accord (amlodipine besilate) SE/H/842/01-02/MR This module reflects the scientific discussion for the approval of Amlodipin Accord 5 mg and 10 mg

More information

Blooms The Chemist Amlodipine / Atorvastatin

Blooms The Chemist Amlodipine / Atorvastatin Blooms The Chemist Amlodipine / Atorvastatin 5/10, 5/20, 5/40, 5/80, 10/10, 10/20, 10/40 & 10/80 TABLETS Contains the active ingredients amlodipine (as besylate) and atorvastatin (as calcium propylene

More information

Effect of Different Carriers on in vitro Permeation of Meloxicam through Rat Skin

Effect of Different Carriers on in vitro Permeation of Meloxicam through Rat Skin Research Paper www.ijpsonline.com Effect of Different Carriers on in vitro Permeation of Meloxicam through Rat Skin M. A. SALEEM *, SUMANJI BALA, LIYAKAT AND A. AEAJAZ Luqman College of Pharmacy, Behind

More information

SCIENTIFIC DISCUSSION

SCIENTIFIC DISCUSSION SCIENTIFIC DISCUSSION 1. SUMMARY OF THE DOSSIER Rheumocam is a generic medicinal product as defined in Article 13(2) (b) of Directive 2001/82/EC, as amended by Directive 2004/28/EC. The reference veterinary

More information

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 1 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Porcilis ColiClos suspension for injection for pigs 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each dose of 2 ml

More information

Amlodipine 5 Mg Tab Cam

Amlodipine 5 Mg Tab Cam Amlodipine 5 Mg Tab Cam what is amlodipine 10 mg used for thuoc amlodipine besylate tablets 5 mg amlodipine 5 mg plus atenolol 50 mg amlodipine 5 mg cost amlodipine besylate 10 mg per tablet amlodipine

More information

Keep this leaflet with your medicine. You may want to read it again. What this medicine is used for

Keep this leaflet with your medicine. You may want to read it again. What this medicine is used for Blooms The Chemist Amlodipine/Atorvastatin 5/10, 5/20, 5/40, 5/80, 10/10, 10/20, 10/40 & 10/80 TABLETS Contains the active ingredients amlodipine (as besylate) and atorvastatin (as calcium propylene glycol

More information

IJBCP International Journal of Basic & Clinical Pharmacology. Adverse drug effects monitoring of amlodipine in a tertiary care hospital

IJBCP International Journal of Basic & Clinical Pharmacology. Adverse drug effects monitoring of amlodipine in a tertiary care hospital Print ISSN: 2319-2003 Online ISSN: 2279-0780 IJBCP International Journal of Basic & Clinical Pharmacology DOI: http://dx.doi.org/10.18203/2319-2003.ijbcp20182069 Original Research Article Adverse drug

More information

Using of polydiallyldimethylammonium chloride for removal Cryptosporidium from the public recreational water venue

Using of polydiallyldimethylammonium chloride for removal Cryptosporidium from the public recreational water venue Available online www.jocpr.com Journal of Chemical and Pharmaceutical Research, 2014, 6(6):39-43 Research Article ISSN : 0975-7384 CODEN(USA) : JCPRC5 Using of polydiallyldimethylammonium chloride for

More information

Summary of Product Characteristics

Summary of Product Characteristics Summary of Product Characteristics 1 NAME OF THE VETERINARY MEDICINAL PRODUCT Orafluke 5% w/v Oral Suspension. 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each 1ml of suspension contains: Active Substances

More information

CORAL ESSENTIALS INFORMATION

CORAL ESSENTIALS INFORMATION CORAL ESSENTIALS INFORMATION Blue Life USA is Proud to offer The Sustainable Reef s - Coral Essentials Method Marine aquarists have known for many years the essential requirement to have a rigorous supplementation

More information

Package leaflet: Information for the user. Amlodipin Aurobindo 10 mg tablets. Amlodipine

Package leaflet: Information for the user. Amlodipin Aurobindo 10 mg tablets. Amlodipine Package leaflet: Information for the user Amlodipin Aurobindo 5 mg tablets Amlodipin Aurobindo 10 mg tablets Amlodipine Read all of this leaflet carefully before you start taking this medicine because

More information